Ekttitab Holding Company K.S.C Public Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, sales was KWD 0.015622 million compared to KWD 0.015622 million a year ago. Revenue was KWD 0.013445 million compared to negative revenue of KWD 0.046636 million a year ago. Net loss was KWD 0.0843 million compared to KWD 0.169104 million a year ago. Basic loss per share from continuing operations was KWD 0.00026 compared to KWD 0.00053 a year ago.